OSTOMYCURE AS
Operating
OstomyCure – A Revolution in Stoma Therapy
A Revolution in Stoma Therapy
Utvikling, produksjon og salg av medisinsk utstyr og annet tilhørende.
Utvikling, produksjon og salg av medisinsk utstyr og annet der er
tilhørende.
Keywords
laboratory equipmentlaboratory furnituresurgicalmedicalinstrumentssurgical equipmentdental technologyequipmentorthodonticgoodsdental prosthesesorthodontic appliancestooth fillingsdental cementsadhesivesdental waxplaster preparationslaboratory ovensultrasonic cleaning machineslaboratory sterilization equipmentsyringesneedlescathetersdental chairsartificial teethbridgeshearing aidsglass eyesthermometersvision aidsglasseslensescontact lenses and gogglescardiac pacemakerslaboratory distillation apparatuslaboratory centrifuges
Organization
- Chairman of the board
- GL
- Years since formation
- 23 years
- since Sep 15, 2003
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 394,946,936
- 1 share class
- Total number of shareholders
- 43
- 10 companies, 33 persons
- Belongs to group of
Financials
- Annual total result 2024
- -12,940,388
- NOK
- Total equity 2024
- 25,259,656
- NOK
Last update: Feb 24, 2026
Locations
- Company addressc/o Kistefos AS Dokkveien 1 0250 OSLO, Norge
Copied!
Management
Board
| Name | Role | Shares |
|---|---|---|
| Board Member | - | |
GL | Chairman | - |
| Board Member | - | |
LM | Board Member | - |
WW | Board Member | - |
GS 1957 | Board Member | - |
MK | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
R RSM NORGE AS | Auditor | - |
T TANDEM AS | Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
CS 1956 | - | 70.38 % indirectly |
Last update: Feb 21, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
K KISTEFOS AS | Ordinary shares | 277,960,440 | 70.38 % |
C CANICA AS | Ordinary shares | 61,414,692 | 15.55 % |
EP | Ordinary shares | 20,000,000 | 5.06 % |
| Ordinary shares | 5,130,434 | 1.3 % | |
M MONOLITTEN INVEST AS | Ordinary shares | 4,643,834 | 1.18 % |
P POTENZA AS | Ordinary shares | 3,433,791 | 0.87 % |
I INVEN2 AS | Ordinary shares | 3,315,466 | 0.84 % |
KT 1949 | Ordinary shares | 2,268,154 | 0.57 % |
| Ordinary shares | 2,231,884 | 0.57 % | |
| Ordinary shares | 2,020,289 | 0.51 % | |
| Ordinary shares | 1,614,185 | 0.41 % | |
| Ordinary shares | 1,350,771 | 0.34 % | |
| Ordinary shares | 1,332,769 | 0.34 % | |
| Ordinary shares | 1,223,677 | 0.31 % | |
| Ordinary shares | 1,054,093 | 0.27 % | |
| Ordinary shares | 994,789 | 0.25 % | |
SS | Ordinary shares | 990,326 | 0.25 % |
| Ordinary shares | 608,695 | 0.15 % | |
| Ordinary shares | 608,695 | 0.15 % | |
| Ordinary shares | 551,870 | 0.14 % | |
| Ordinary shares | 452,173 | 0.11 % | |
BP | Ordinary shares | 383,759 | 0.1 % |
E EMGANI AS | Ordinary shares | 210,000 | 0.05 % |
LH 1947 | Ordinary shares | 128,000 | 0.03 % |
| Ordinary shares | 125,350 | 0.03 % | |
C CONSULTA AS | Ordinary shares | 115,473 | 0.03 % |
| Ordinary shares | 114,754 | 0.03 % | |
| Ordinary shares | 114,000 | 0.03 % | |
| Ordinary shares | 105,000 | 0.03 % | |
J JFBG AS | Ordinary shares | 85,000 | 0.02 % |
| Ordinary shares | 59,000 | < 0.01 % | |
T TRANSVEGA AS | Ordinary shares | 53,577 | < 0.01 % |
| Ordinary shares | 44,000 | < 0.01 % | |
F FIRST PARTNERS HOLDING 8 AS | Ordinary shares | 40,154 | < 0.01 % |
UL 1963 | Ordinary shares | 38,250 | < 0.01 % |
| Ordinary shares | 31,252 | < 0.01 % | |
| Ordinary shares | 25,000 | < 0.01 % | |
| Ordinary shares | 15,000 | < 0.01 % | |
| Ordinary shares | 11,700 | < 0.01 % | |
| Ordinary shares | 11,660 | < 0.01 % | |
| Ordinary shares | 11,660 | < 0.01 % | |
| Ordinary shares | 11,660 | < 0.01 % | |
| Ordinary shares | 11,660 | < 0.01 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 754,000Operating profit 2024: NOK -14,395,000Employees: 7
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | -12,940,388 | -16,727,127 | -14,518,138 | -7,580,743 |
Total assets | 42,218,906 | 22,835,252 | 23,274,273 | 22,434,963 |
Total liabilities | 16,959,250 | 25,670,444 | 29,874,925 | 14,517,478 |
Total equity | 25,259,656 | -2,835,192 | -6,600,652 | 7,917,486 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 11,505,438 | 13,098,247 | 13,403,675 | 7,926,554 |
Operating result | -11,505,438 | -13,098,247 | -13,403,675 | -7,926,554 |
Financial income/costs | -1,434,950 | -3,628,879 | -1,114,463 | 345,811 |
Profit before tax | -12,940,388 | -16,727,127 | -14,518,138 | -7,580,743 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -12,940,388 | -16,727,127 | -14,518,138 | -7,580,743 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 28,830,184 | 18,830,184 | 15,680,184 | 15,680,184 |
Total current assets | 13,388,723 | 4,005,068 | 7,594,089 | 6,754,780 |
Total assets | 42,218,906 | 22,835,252 | 23,274,273 | 22,434,963 |
Short term debt | 16,959,250 | 25,670,444 | 29,874,925 | 14,517,478 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 16,959,250 | 25,670,444 | 29,874,925 | 14,517,478 |
Contributed capital | 22,197,636 | 36,286,762 | 15,794,176 | 15,794,176 |
Retained earnings | 3,062,020 | -39,121,954 | -22,394,827 | -7,876,690 |
Total equity | 25,259,656 | -2,835,192 | -6,600,652 | 7,917,486 |
Total equity and liabilities | 42,218,906 | 22,835,252 | 23,274,273 | 22,434,963 |
Classification
21st company classification
BETA
Industrial daughter company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
32
Activity
Other manufacturing
32.5
Main industrial group
Manufacture of medical and dental instruments and supplies
32.50
Industrial group
Manufacture of medical and dental instruments and supplies
32.500
Industrial group
Manufacture of medical and dental instruments and supplies